Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 13/20 | 0.46 |
| ▸ | JAK2 | O60674 | 9/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | TYK2 | P29597 | 4/20 | 0.35 |
| ▸ | JAK3 | P52333 | 4/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2278886 | 0.89 | JAK1 (0.37) | JAK1JAK2TYK2JAK3MAPT | |
| SCHEMBL2279561 | 0.89 | JAK1 (0.37) | JAK1JAK2HTR1ADRD2HTR2A | |
| SCHEMBL2277562 | 0.84 | JAK1 (0.51) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2276029 | 0.81 | JAK1 (0.48) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2283256 | 0.81 | JAK1 (0.48) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2272441 | 0.81 | JAK1 (0.52) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2281791 | 0.80 | JAK1 (0.50) | JAK1JAK2TYK2JAK3KMT2A | |
| SCHEMBL2280651 | 0.80 | JAK1 (0.48) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2277351 | 0.80 | JAK1 (0.53) | JAK1JAK2TYK2JAK3 | |
| SCHEMBL2274424 | 0.79 | JAK1 (0.45) | JAK1JAK2TYK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |